WO2001079467A3 - Identification d'une nouvelle nadph-oxydase renale - Google Patents
Identification d'une nouvelle nadph-oxydase renale Download PDFInfo
- Publication number
- WO2001079467A3 WO2001079467A3 PCT/US2001/010866 US0110866W WO0179467A3 WO 2001079467 A3 WO2001079467 A3 WO 2001079467A3 US 0110866 W US0110866 W US 0110866W WO 0179467 A3 WO0179467 A3 WO 0179467A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- renal
- invention includes
- mammalian renal
- treating
- Prior art date
Links
- 108010002998 NADPH Oxidases Proteins 0.000 title abstract 6
- 102000004722 NADPH Oxidases Human genes 0.000 title abstract 5
- 238000000034 method Methods 0.000 abstract 5
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010023424 Kidney infection Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000008601 Polycythemia Diseases 0.000 abstract 1
- 206010037596 Pyelonephritis Diseases 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Cette invention se rapporte à des acides nucléiques et à leurs polypeptides codés correspondant à de nouvelles NADPH-oxydases rénales mammaliennes, et à des utilisations de ces acides nucléiques et polypeptides. Cette invention concerne des compositions thérapeutiques correspondant à ces nouvelles NADPH-oxydases rénales mammaliennes, des vecteurs d'expression contenant ces acides nucléiques et des lignées cellulaires transformées contenant ces vecteurs d'expression, ainsi que des procédés de traitement de patients à l'aide de compositions thérapeutiques correspondant à ces nouvelles NADPH-oxydases rénales mammaliennes et des procédés pour produire les polypeptides faisant l'objet de cette invention. Cette invention concerne en outre des dosages permettant de découvrir des composés qui ont la fonction de protéines codées par des acides nucléiques de ces nouvelles NADPH-oxydases rénales mammaliennes, un procédé pour traiter ou prévenir le cancer, l'hypertension, les maladies rénales inflammatoires et les infections des voies urinaires, et un procédé pour traiter des patients souffrant de polycythémie, ainsi qu'un procédé pour déterminer la séquence d'un gène de NADPH-oxydases rénales mammaliennes dans un échantillon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001253123A AU2001253123A1 (en) | 2000-04-12 | 2001-04-03 | Identification of a renal nadph oxidase |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19634100P | 2000-04-12 | 2000-04-12 | |
US60/196,341 | 2000-04-12 | ||
US21262900P | 2000-06-19 | 2000-06-19 | |
US60/212,629 | 2000-06-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001079467A2 WO2001079467A2 (fr) | 2001-10-25 |
WO2001079467A3 true WO2001079467A3 (fr) | 2003-01-23 |
Family
ID=26891837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/010866 WO2001079467A2 (fr) | 2000-04-12 | 2001-04-03 | Identification d'une nouvelle nadph-oxydase renale |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001253123A1 (fr) |
WO (1) | WO2001079467A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1399565A2 (fr) * | 2000-11-16 | 2004-03-24 | Emory University | Regulateurs d'oxygenase mitogeniques |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001053312A1 (fr) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
-
2001
- 2001-04-03 AU AU2001253123A patent/AU2001253123A1/en not_active Abandoned
- 2001-04-03 WO PCT/US2001/010866 patent/WO2001079467A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001053312A1 (fr) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
Non-Patent Citations (6)
Title |
---|
DATABASE EMBL [online] 15 March 2000 (2000-03-15), YANG S. ET AL.: "Mus musculus superoxide-generating oxidase mRNA, complete cds.", XP002209503, retrieved from EBI Database accession no. AF218723 * |
DATABASE GENESEQ [online] 22 January 2002 (2002-01-22), "WO200153312 ,Human polypeptide SEQ ID NO 3483", XP002209504, retrieved from EBI Database accession no. AAM40338 * |
DATABASE GENESEQ [online] 22 October 2001 (2001-10-22), "WO0153312 SEQ ID NO 3484", XP002209505, retrieved from EBI Database accession no. AAM40339 * |
GEISZT MIKLOS ET AL: "Identification of Renox, an NAD(P)H oxidase in kidney.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 14, 5 July 2000 (2000-07-05), July 5, 2000, pages 8010 - 8014, XP002209502, ISSN: 0027-8424 * |
YANG S ET AL: "Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts.", CALCIFIED TISSUE INTERNATIONAL, vol. 63, no. 4, October 1998 (1998-10-01), pages 346 - 350, XP001097147, ISSN: 0171-967X * |
YANG SU ET AL: "A new superoxide-generating oxidase in murine osteoclasts.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 8, 23 February 2001 (2001-02-23), pages 5452 - 5458, XP002209501, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001253123A1 (en) | 2001-10-30 |
WO2001079467A2 (fr) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2305715A3 (fr) | Anticorps monoclonal contre la protéine de liaison d'ostéoprotégérine | |
TW200745556A (en) | Biomarkers for liver fibrotic injury | |
WO2002020569A3 (fr) | Genes mammaliens, reactifs et methodes associes | |
WO2003057850A3 (fr) | Proteines de liaison en tant que biocapteurs | |
WO2003014303A3 (fr) | Interactions moleculaires dans les cellules | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
WO2004033631A8 (fr) | Sequences d'acides nucleiques et polypeptidiques de lawsonia intracellularis et methodes d'utilisation | |
WO2002029086A3 (fr) | Sequences d'acide nucleique differentiellement exprimees dans un tissu cancereux | |
WO2002092818A3 (fr) | Sequence du genome streptococcus agalactiae et ses utilisations | |
WO2002006457A3 (fr) | Genes de lipase | |
WO2003042401A3 (fr) | Nouveaux chromophores/fluorophores et leurs procedes d'utilisation | |
AU4985201A (en) | Human gene critical to fertility | |
WO2003038055A3 (fr) | Proteines impliquees dans la regulation des adipocytes et utilisations associees | |
WO2001093851A3 (fr) | Compositions et procedes pour traiter une affection neoplasique au moyen d'inhibiteurs de laminine 5 beta 3 | |
DE60132443D1 (de) | In lebenden zielzellen | |
WO2003062453A3 (fr) | Acides nucleiques et proteines associes a la polykystose renale | |
WO2001057219A3 (fr) | Cytokines mammaliennes, leurs recepteurs, reactifs et procedes correspondants | |
Kwak et al. | Controlled surface immobilization of viruses via site-specific enzymatic modification | |
WO2001079467A3 (fr) | Identification d'une nouvelle nadph-oxydase renale | |
WO2004042345A3 (fr) | Systeme a trois hybrides de petites molecules bacteriennes | |
AU4908799A (en) | Determination of the hydrophobic pulmonary surfactant protein sp-c | |
WO1999047673A3 (fr) | Genes de proteines membranaires mammiferes isoles, et reactifs associes | |
WO2001019860A3 (fr) | Proteines associees a la differenciation cellulaire | |
WO2004094989A3 (fr) | Methodes d'analyse de proteines de cellule hote | |
WO2001036463A3 (fr) | Genes de mammifere, reactifs associes et procedes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |